Non-Small Cell Lung Cancer (NSCLC)
Aug 04, 2017
CDK 4/6 Inhibitors- The Changing Paradigm for Breast Cancer Treatment
The discovery of Cyclin Dependent Kinases (CDKs) is a result of increasing number of cancer cases worldwide. The development of CDKs has changed the paradigm for cancer treatment and it has gradually become an interesting area of research in oncology. The research on CDK inhibitors gained momentum because of the fre...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
